Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MT-CO2 | P00403 | 1/20 | 0.33 |
| ▸ | F2 | P00734 | 2/20 | 0.31 |
| ▸ | STAT5B | P51692 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29621739 | 1.00 | MT-CO2 (0.33) | MT-CO2F2STAT5B | |
| SCHEMBL20340241 | 0.95 | STAT5B (0.33) | MT-CO2F2STAT5B | |
| SCHEMBL29621894 | 0.84 | L3MBTL1 (0.38) | STAT5B | |
| SCHEMBL4696750 | 0.83 | SYK (0.32) | — | |
| SCHEMBL29621907 | 0.83 | MT-CO2 (0.33) | MT-CO2 | |
| SCHEMBL26317886 | 0.83 | MT-CO2 (0.33) | MT-CO2 | |
| SCHEMBL20338985 | 0.80 | L3MBTL1 (0.37) | STAT5B | |
| SCHEMBL29621719 | 0.80 | KMT2A (0.42) | — | |
| SCHEMBL20340242 | 0.78 | MT-CO2 (0.32) | MT-CO2STAT5B | |
| SCHEMBL20338963 | 0.76 | KMT2A (0.42) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11739072-B2 | Heteroaryl compounds and their use | MINORYX THERAPEUTICS S.L. (ES) | 2023-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11739072-B2 | Heteroaryl compounds and their use | GBA1, GBA2, GAA | MT-CO2 2461/4885F2 2469/4885STAT5B 4697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.